Content area

|
|

Diskussion om Food and Drug Administrations rolle, når tiderne skifter

Forfatter(e)
Niels Keiding Biostatistisk Afdeling, Københavns Universitet Ugeskr Læger 2018;180:V11170868
Reference: 
Ugeskr Læger 2018;180:V11170868
Blad nummer: 
Sidetal: 
2-4
The role of the Food and Drug Administration as times change
The prestigious journal Biostatistics published in July 2017 six solicited commentaries on the role of the U.S. Food and Drug Administration (FDA), as times change, with ever developing technical tools for clinical trials and their evaluation, with increased focus on personalised medicine (possibly aided by genetic testing), and on patient self-determination. Two were written by American economists, four by leading biostatisticians, mostly from the USA. This paper summarises these texts for a Danish audience.
Du skal være logget ind for at læse denne artikel
Log ind

Right side

af Camilla Bang | 16/10
1 Kommentar
af Tobias Ramm Eberlein | 15/10
6 kommentarer
af Frank Bang Nissen | 15/10
1 Kommentar
af Peter Hvidbak Revald | 14/10
3 kommentarer
af Arne Mejlhede | 11/10
1 Kommentar
af Sven Refslund Poulsen | 06/10
3 kommentarer
af Bent Varming | 05/10
2 kommentarer